Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma.
Robert A Parise, Jan H Beumer, Cyrous O Kangani, Julianne L Holleran, Julie L Eiseman, Nicola F Smith, Joseph M Covey, Susan P Perrine, Merrill J Egorin
文献索引:J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 862(1-2) , 168-74, (2008)
全文:HTML全文
摘要
2,2-Dimethylbutyrate (DMB) is a potential treatment for thalassemia and hemoglobinopathies. To facilitate pharmacokinetic evaluation of DMB, we developed an LC-MS assay and quantitated DMB in plasma of rats after an oral dose of 500mg/kg. After acetonitrile protein precipitation, DMB and dimethylvaleric acid (DMV) internal standard were derivatized to benzylamides, chromatographed on a Hydro-RP column with acetonitrile, water, and 0.1% formic acid, and detected by electrospray positive-mode ionization mass spectrometry. The assay was accurate (97-107%) and precise (3.4-6.2%) between 100 and 10,000ng/mL. Recovery from plasma was >62%. Plasma freeze-thaw and room temperature stability were acceptable.
相关化合物
相关文献:
2003-07-01
[Zhongguo Zhong Yao Za Zhi 28(7) , 627-9, (2003)]
2013-05-01
[Br. J. Haematol. 161(4) , 587-93, (2013)]
2012-11-01
[Am. J. Hematol. 87(11) , 1017-21, (2012)]
2011-08-01
[J. Clin. Pharmacol. 51(8) , 1186-94, (2011)]
2013-11-01
[Am. J. Hematol. 88(11) , E255-60, (2013)]